Cargando…
Role of CyPA in cardiac hypertrophy and remodeling
Pathological cardiac hypertrophy is a complex process and eventually develops into heart failure, in which the heart responds to various intrinsic or external stress, involving increased interstitial fibrosis, cell death and cardiac dysfunction. Studies have shown that oxidative stress is an importa...
Autores principales: | Cao, Mengfei, Yuan, Wei, Peng, Meiling, Mao, Ziqi, Zhao, Qianru, Sun, Xia, Yan, Jinchuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928530/ https://www.ncbi.nlm.nih.gov/pubmed/31825469 http://dx.doi.org/10.1042/BSR20193190 |
Ejemplares similares
-
Corosolic acid ameliorates cardiac hypertrophy via regulating autophagy
por: Wang, Zhao-Peng, et al.
Publicado: (2019) -
Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice
por: Alharbi, Hajed O., et al.
Publicado: (2022) -
Central role for BRAF in cardiac hypertrophy: rethinking the pathological–physiological divide
por: Altara, Raffaele, et al.
Publicado: (2023) -
Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy
por: Gao, Maomao, et al.
Publicado: (2020) -
Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo
por: Clerk, Angela, et al.
Publicado: (2022)